Pancreatic Neoplasms
Showing 26 - 50 of 247
Pancreatic Cyst, Pancreatic Tumors, Pancreatic Cancer Trial in San Francisco (Survey)
Recruiting
- Pancreatic Cyst
- +7 more
- Survey
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 20, 2022
Transversus Abdominis Plane Block on Analgesia After Cephalic
Recruiting
- Pancreatic Neoplasms
-
Strasbourg, FranceService d'Anesthésie, Réanimation et Médecine péri-Opératoire -
Sep 15, 2022
Tumors, NSCLC, Pancreatic Tumors Trial in Worldwide (V941, Pembrolizumab)
Completed
- Neoplasms
- +3 more
- V941
- Pembrolizumab
-
Gilbert, Arizona
- +25 more
Sep 5, 2022
Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)
Not yet recruiting
- Pancreatic Neoplasms
- +2 more
- BI 907828
- (no location specified)
Aug 22, 2022
Pancreatic Tumors Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)
Recruiting
- Pancreatic Neoplasms
- Penpulimab
- +3 more
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 10, 2022
Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)
Recruiting
- Advanced Solid Tumor
- +18 more
- PT199
- Anti-PD-1 monoclonal antibody
-
Huntersville, North Carolina
- +2 more
Aug 10, 2022
LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)
Recruiting
- Pancreatic Neoplasms
-
Osaka, Lyn010001, Japan
- +46 more
Aug 4, 2022
Pancreatic Tumors, Anesthesia Trial in Barcelona (Multimodal Prehabilitation)
Recruiting
- Pancreatic Neoplasms
- Anesthesia
- Multimodal Prehabilitation
-
Barcelona, SpainHospital Clinic de Barcelona
Aug 3, 2022
Pancreatic Tumors, Periampullary Carcinoma Trial in Cleveland (other, dietary supplement, behavioral)
Enrolling by invitation
- Pancreatic Neoplasms
- Periampullary Carcinoma
- Exercise
- +3 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Center, Case Comprehensive Cance
Aug 3, 2022
Pancreatic Tumors Trial in Guangzhou (Surufatinib, TAS-102)
Not yet recruiting
- Pancreatic Neoplasms
-
Guangzhou, Guangdong, ChinaCancer center of SunYat-sen University
Jul 28, 2022
Pancreatic Tumors Trial in Guangzhou (Surufatinib, Sintilimab, AG)
Not yet recruiting
- Pancreatic Neoplasms
- Surufatinib
- +2 more
-
Guangzhou, Guangdong, ChinaCancer center of SunYat-sen University
Jul 28, 2022
NSCLC, Colorectal Neoplams, Endometrial Tumors Trial in Worldwide (LY3537982, Abemaciclib, Erlotinib)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +4 more
- LY3537982
- +7 more
-
Los Angeles, California
- +21 more
Jul 22, 2022
Mesothelioma, Mesotheliomas Pleural, Mesothelioma, Malignant Trial in Bethesda, Nashville (TC-510, Fludarabine,
Recruiting
- Mesothelioma
- +14 more
- TC-510
- +2 more
-
Nashville, TennesseeSarah Cannon Research Institute
Jul 14, 2022
Biliary Disease, Pancreatic Disease, Choledocholithiasis Trial in Palo Alto (Duodenoscope with single-use distal cover,
Not yet recruiting
- Biliary Disease
- +5 more
- Duodenoscope with single-use distal cover
- Conventional duodenoscope
-
Palo Alto, CaliforniaStanford hospital
Jun 17, 2022
Pancreatic Cancer, Pancreatic Tumors, Pancreatic Ductal Adenocarcinoma Trial in Shanghai (Cyclophosphamide, Fludarabine, Mutant
Recruiting
- Pancreatic Cancer
- +3 more
- Cyclophosphamide
- +3 more
-
Shanghai, ChinaChanghai Hospital
Jun 13, 2022
Histologically or Cytologically Confirmed Pancreatic Cancer, Unresectable or Borderline Resectable Pancreatic Cancer, Pancreatic
Terminated
- Histologically or Cytologically Confirmed Pancreatic Cancer
- +4 more
- M7824
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 19, 2022
Pancreas Cancer, Pancreas Tumor, Pancreas Adenocarcinoma Trial (Laparoscopic surgical biopsy and organoid generation)
Not yet recruiting
- Pancreas Cancer
- +5 more
- Laparoscopic surgical biopsy and organoid generation
- (no location specified)
Apr 22, 2022
Study of Patients With Malignant Mesothelioma
Recruiting
- Mesothelioma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
Pancreatic Tumor, Benign, Pancreatic Tumors, Pancreatic Adenocarcinoma Trial in Houston (Distal Pancreatectomy Sealing Using
Completed
- Pancreatic Tumor, Benign
- +13 more
- Distal Pancreatectomy Sealing Using LTW
-
Houston, TexasBaylor CHI St. Luke's Medical Center
Apr 4, 2022
Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)
Recruiting
- Adenocarcinoma
- +9 more
- Nab-paclitaxel
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Mar 15, 2022
Tumors, Pancreatic Tumors Trial run by the NCI (LMB-100, Nab-Paclitaxel, Mesothelin Expression)
Completed
- Neoplasms
- Pancreatic Neoplasms
- LMB-100
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 16, 2022
Pancreatic Tumors, Pancreatic Cancer Trial in United States (Bardoxolone methyl, Gemcitabine, Placebo)
Terminated
- Pancreatic Neoplasms
- Pancreatic Cancer
- Bardoxolone methyl
- +2 more
-
Denver, Colorado
- +4 more
Feb 4, 2022
Lipidomics, Proteomics, Micro RNAs and Volatile Organic
Active, not recruiting
- Pancreatic Neoplasms
- blood and bile
-
Orlando, FloridaAdventHealth
Feb 15, 2022